ROS: Really involved in Oxygen Sensing  by Kaelin, William G.
P R E V I E WROS: Really involved in Oxygen Sensing
The role of reactive oxygen species (ROS) in the cellular response to cellular oxygen sensing has been controversial.
Three papers in this issue of Cell Metabolism (Brunelle et al., 2005; Guzy et al., 2005; Mansfield et al., 2005) used genetic
tools to establish that ROS produced by mitochondria are required for the normal induction of HIF (hypoxia-inducible
factor), which is a master regulator of oxygen-sensitive gene expression, by low oxygen.Understanding how cells sense and b
adapt to changes in oxygen availability c
iis important, in part because the leading
causes of death in the developed world p
Eare diseases such as myocardial in-
farction, cancer, and stroke, which are
(characterized by impaired tissue oxy-
genation. Over the years, there have β
cbeen contradictory reports as to the im-
portance of mitochondria, as well as H
treactive oxygen species (ROS), with re-
spect to oxygen sensing. Three papers g
gin this issue of Cell Metabolism strengthen
the earlier contention that ROS gener- t
tated by mitochondria under low-oxygen
(hypoxic) conditions play an important a
crole in this process (Brunelle et al., 2005;
Guzy et al., 2005; Mansfield et al., 2005). m
pDeconvoluting complex biological pro-
cesses usually requires both genetic and t
ibiochemical approaches to establish
causality and mechanism. Several com- o
ponents of the pathway used by meta- t
zoans to respond to changes in oxygen u
have now been genetically validated and HIF-α for destruction when oxygen is g
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Figure 1. Regulation of HIF stability by reactive oxygen species
In the presence of oxygen, the α subunit of the heterodimeric transcription factor HIF is hydroxylated on one t
of two conserved prolyl residues by EglN. This creates a binding site for a ubiquitin ligase that contains pVHL i
(for simplicity, the other components of the pVHL complex are not shown). Polyubiquitination targets HIF-α p
subunits for destruction. EglN requires oxygen, Fe2+, 2-oxoglutarate, and ascorbate. Low-oxygen conditions
hinhibit prolyl hydroxylation by limiting the amount of oxygen available for the hydroxylation reaction and
through increased ROS, which might oxidize EglN bound iron. nCELL METABOLISM : JUNE 2005iochemically characterized. These in- p
alude transcription factor HIF (hypoxia-
nducible factor), the von Hippel-Lindau H
trotein (pVHL), and prolyl hydroxylase
glN (also called HPH or PHD). n
tHIF consists of a labile α subunit
such as HIF-1α or HIF-2α) and a stable (
isubunit (such as HIF-1β, which is also
alled ARNT). Under hypoxic conditions, c
BIF-α is stabilized, binds to HIF-β, and
ranscriptionally activates a cadre of 2
tenes involved in adaptation to low oxy-
en. But how is HIF-α stability coupled E
co changes in oxygen? A clue came from
he study of von Hippel-Lindau disease, p
nhuman hereditary cancer syndrome
aused by inactivation of the pVHL tu-
mor-suppressor protein. In cells lacking
VHL, HIF-α is relatively stable irrespec- g
tive of changes in ambient oxygen, lead-
ng to the constitutive activation of hyp- m
xia-inducible genes. Later, it was shown i
hat pVHL is the substrate adaptor for a 2
biquitin ligase complex that targets tresent. The interaction between pVHL
nd HIF-α is oxygen sensitive because
IF-α must be hydroxylated on one of
wo prolyl residues in order to be recog-
ized by pVHL (Kaelin, 2004). This reac-
ion is intrinsically oxygen dependent
the oxygen atom of the hydroxyl group
s derived from molecular oxygen) and is
arried out by EglN (Epstein et al., 2001;
ruick and McKnight, 2001; Ivan et al.,
002; Figure 1). In human cells, there are
hree EglN family members (EglN1,
glN2, and EglN3), although EglN1 (also
alled PHD2 or HPH2) appears to be the
rimary HIF prolyl hydroxylase under
ormal conditions (Berra et al., 2003).
Elimination of the single EglN family
ember in C. elegans and D. melano-
aster leads to constitutive HIF stabiliza-
ion, as does elimination of EglN1 from
ammalian cells (Berra et al., 2003; Bru-
ck and McKnight, 2001; Epstein et al.,
001). In addition, EglN hydroxylase ac-
ivity is very sensitive to changes in oxy-
en availability in vitro because of its rel-
tively high Km for oxygen (Epstein et
l., 2001; Hirsila et al., 2003). Therefore,
glN1 is an excellent candidate to be an
xygen sensor. However, EglN did not
volve in a test tube but rather evolved
o function in the complex environment
f a cell. It is conceivable that a number
f inputs impinge upon EglN activity and
ontribute to the hypoxic response.
n this regard, these enzymes require
-oxoglutarate (which is converted to
uccinate during the hydroxylation reac-
ion), ascorbate, and Fe2+ in addition to
xygen. There is already experimental
vidence supporting the prediction that
glN1 activity is sensitive to changes in
ntracellular succinate levels, through
eedback inhibition, and to changes in
edox status (Gerald et al., 2004; Selak
t al., 2005).
In 1998, the senior authors of the
hree papers in this issue, then work-
ng together, reported that mitochondria
roduced a burst of ROS in response to
ypoxia and that this burst was both
ecessary and sufficient to stabilize HIF357
P R E V I E Wt(Chandel et al., 1998). This work was ini-
ttially met with some skepticism, in part
abecause it relied heavily on pharmaco-
tlogical tools and because others re-
tported that cells lacking mitochondria
dstill stabilized HIF in response to hypoxia
t(Kaelin, 2004). The current papers use a
svariety of approaches to substantiate
their earlier claims. t
First, Guzy et al. (2005) used a novel H
FRET probe containing a redox-sensi- A
tive linker to confirm the earlier conclu- w
sion, reached with redox-sensitive dyes, p
that hypoxia leads to increased ROS v
production. Along with Brunelle et al. e
(2005), they then used siRNA to inacti- t
vate the Rieske iron-sulfur protein of m
mitochondrial complex III to abrogate c
this burst; Mansfield et al. (2005) ex- l
ploited cells in which the cytochrome c c
locus was disrupted to accomplish this p
end. Blocking ROS production, geneti- o
cally or pharmacologically, led to im- l
paired HIF induction by hypoxia. Con- m
versely, treating cells with agents that
produce ROS induced HIF. Importantly, e
HIF could still be induced by profound w
hypoxia (anoxia) in cells in which ROS t
production was experimentally sup- y
pressed, arguing that ROS produced s
by the mitochondria alter the shape of n
the oxygen/prolyl hydroxylation dose-
t
response curve. This might partially ex-
splain the conflicting reports regarding
athe necessity of mitochondria for oxy-
tgen sensing. It is likely that ROS pro-
fduced in response to hypoxia affect the
loxidation status of EglN bound iron,
although this remains to be proven
W
(Figure 1).
One caveat, highlighted by a recent
Hstudy of the effects of nitric oxide on HIF,
Drelates to the possibility that perturbing
Bmitochondrial function could decrease
Hoxygen consumption (Hagen et al., 2003).
BIn theory, this could lead to increased in-358Sracellular oxygen concentrations and
hus suppress HIF induction at a given
B
mbient oxygen concentration. The au- R
hors of the present studies attempted 2
o control for this by showing that cells
B
efective in oxidative phosphorylation or 2
reated with various mitochondrial poi-
Bons that decrease oxygen consump- c
ion without generating ROS induced R
IF normally under hypoxic conditions. t
decrease in oxygen consumption C
ould also not readily explain the im- t
Pairment of HIF induction observed with
arious peptidic and organic ROS scav- E
ngers. Nonetheless, it will be important K
Eo determine whether any of the experi-
4ental manipulations carried out in the
urrent papers indirectly affect intracel- G
Gular oxygen, succinate, or ascorbate
Moncentrations. Likewise, it will be im-
7
ortant to gain a clearer understanding
Gf how decreased oxygen availability
Leads to increased ROS production by
U
itochondrial complex III. t
As recently as five years ago, knowl-
H
dge of oxygen sensing by metazoans (
as a bewildering morass. In this con-
Hext, control of HIF stability by an ox- K
gen-dependent enzyme provided a 2
atisfying and surprisingly simple expla-
I
ation for how changes in oxygen are s
ranslated into changes in gene expres- k
Kion. The current papers suggest that
9dditional layers of complexity are about
Ko be added to this picture, no doubt re-
Plecting the importance of oxygen in cel-
aular homeostasis.
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